THRX Financial Facts
Research and development: 286KInterest expense: -13.1M
See Full Income Statement
Accumulated other comprehensive income (loss): 8K
Property and equipment, net: 381K
See Full Balance Sheet
Theravance Inc. (THRX) Earnings
|
Expand Research on THRX
Next EPS Date | 5/8/24 *Est. | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -408.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/7/24 | Q423 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/13/23 | Q323 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/20/23 | Q323 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/27/23 | Q323 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/10/23 | Q223 | -$0.34 | -$0.35 | +$0.01 | N/A | N/A | N/A | Details | |||
5/11/23 | Q123 | -$0.34 | -$0.41 | +$0.07 | N/A | N/A | N/A | Details | |||
3/9/23 | Q422 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/3/22 | Q322 | -$0.24 | -$0.32 | +$0.08 | N/A | N/A | N/A | Details |